The Total Addressable Market (TAM) for capnography device was valued at USD 613.31 million in 2022. It is estimated to reach USD 1388.06 million by 2031, growing at a CAGR of 9.5% during the forecast period 2023-2031.
A Capnography device is used for patient safety during anesthesia and sedation. It helps in diagnosing the cause of the respiratory ailment. Capnography is critical during Cardiopulmonary Resuscitation (CPR) as it delivers breath-to-breath ventilation data with real-time feedback. It is utilized for monitoring the concentration or partial pressure of exhaled carbon dioxide. Capnography is a sophisticated device necessitating skilled professionals to operate.
The increasing need for capnography devices in prolonged illnesses and protracted treatments associated with lung diseases is expected to tap ample opportunities in the market. According to the study by Cancer Research U.K., the increasing death toll due to cancer globally has compelled clinical perseverance to embrace advanced alternatives, such as capnography devices. According to the American Cancer Society, in 2018, almost 1.7 million new cancer cases were registered in the U.S., and nearly 0.6 million individuals died.
Factors affecting the capnography device market in the future are
The prevalence and health impact of chronic respiratory disorders are estimated by the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017. With a 39.8% rise since 1990, 545 million people globally had the chronic respiratory disease in 2017. The airways and other lung tissues deteriorate due to chronic respiratory diseases (CRDs). Among the most prevalent are asthma, pulmonary hypertension, occupational lung problems, and chronic obstructive pulmonary disease (COPD). According to the World Health Organization, 262 million people worldwide have asthma. Respiratory discomfort is one of the most often reported patient concerns. Waveform capnography is a beneficial method for pinpointing the cause and severity of respiratory distress, directing therapeutic choices, and tracking the patient's response to care. Increasing Respiratory Illness.
Capnography provides objective data on physical exam results, enabling the determination of the degree of respiratory distress. Reduced effort, anxiety, and respiratory rate can signify improved or deteriorated respiratory failure. Waveform capnography helps make a conclusive decision that will direct future treatment. There is a high demand for capnography equipment due to all the benefits that capnography offers patients with respiratory conditions.
One of the main elements driving the adoption of these items worldwide is the growing technological progress in capnography equipment. Due to the development of novel approaches that are essential in monitoring respiratory function, the usage of capnography equipment for precise and effective airway management has increased. One of the key factors expected to propel the market growth globally is the rising preference for minimally invasive treatments for respiratory disorders. Additionally, several market participants have adopted a streamlined and contemporary device approach, resulting in a safer, more effective capnography instrument that produces the best results.
The need for qualified experts with the technical know-how to handle capnography equipment could expand the market. Because capnography equipment is sophisticated, it must be handled by skilled personnel. The usage of these technologies may be constrained by a need for more skilled labor, particularly in developing countries. The expensive nature of some capnography devices may also prevent the market from expanding. Additionally, the U.S. FDA closely monitors the advancement of these devices and grants commercialization permission for their effectiveness.
The growing development of portable capnography is one of the trends in the capnography equipment market. The market for capnography is developing as capnometers become increasingly preferred to oximetry. Demand on the market is also being boosted by an increase in minimally invasive and non-invasive procedures. The high Cost of these devices would constrain the size of the prospective market. In addition, the industry's expansion is being slowed by strict regulatory approval procedures for these devices. Additionally, the market will have significant growth chances due to expanding broad investment and the strong growth potential of emerging nations.
To understand the capnography device market in an all-inclusive manner, we have considered the Product, Technology, application, and end-user as the critical segmentation criteria.
The handheld product segment, among other product segments, is expected to hold the largest share of the market within the forecast period. This device is small and light in weight and is used for measuring the carbon dioxide in respiratory gases in adults, pediatrics, and infant patients. Multi-parameter is one of the products, which can evaluate two or more parameters simultaneously.
The mainstream segment, among other technology segments, is spearheading the market owing to its advantages, such as higher precision, faster response time, and better suitability for infants and children. Both mainstream and sidestream technology provides numerous benefits for the healthcare sector. Still, mainstream Technology comes with further merits, such as no pollution of the operating room environment, no obstruction, and eliminates the need for gas sampling and scavenging as the measurement is done at the airway.
The trauma and emergency care segment, among other application segments, is expected to witness substantial growth. Consumer awareness regarding clinical benefits offered by advanced devices for managing trauma cases is increasing, propelling the trauma and emergency care segment in the market. A Capnography device is used in emergency cases in healthcare centers to measure and correctly adjust the ventilation parameters within a short period.
The hospital segment, among other end-use segments, is gaining significant traction in the market due to its ability to calculate ventilator measurements of intubated patients, its minimally invasive nature, and its ease of use. Waveform capnography is one of hospital equipment's latest and most innovative measurement methodologies. It analyzes the amount of CO2 in the patient's exhaled breath and provides quick and accurate ways to assess the status in a wide variety of conditions.
To evaluate the global capnography device market more comprehensively, we have explored the market across five regions: North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
The North American capnography device market is expected to hold a significant share during the forecast period, owing to the rising prevalence of respiratory diseases due to unhealthy lifestyles and high-stress levels. Hence, respiratory disease is endemic in the region, resulting in an increasing death toll. To address this issue, the deliberate demand for smaller capnography devices has subsequently increased in North America. The Lubbock hospital in Texas recently launched a new waveform technology, capnography, which has numerous benefits compared to traditional devices.
The European capnography equipment market is divided into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe now has a sizable market share and is anticipated to develop quickly over the following years. The expansion of life science research and rising R&D spending in the area fuel the market growth.
The of Asia-Pacific in the global capnography device market can be attributed to the increasing awareness and rising incidents of preterm birth. Moreover, several government initiatives regarding health safety are also expected to provide an impetus to regional market growth. Moreover, other regional market drivers include improving healthcare systems, rising healthcare spending, and increasing awareness about adopting capnography technology.
The LAMEA capnography device market is expected to witness steady growth during the forecast period. This is attributed to the vogue of plastic surgery and the prevalence of respiratory ailments. Latin America comprises several emerging nations where nearly 600 million inhabitants exhibit a demographic transition that combines significant population growth with a progressive geriatric population. The region has a vast majority of asthma patients receiving inadequate care in terms of diagnosis and monitoring, resulting in a substantial morbidity rate.
The major players in the market are
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
In June 2022, GE Healthcare received CE mark approval for combining cutting-edge INVOS regional oximetry and Microstream capnography technologies on the CARESCAPE precision monitoring platform. As a result, GE Healthcare will be able to incorporate clinically sophisticated parameters to give doctors the tools they need for precise monitoring and customized care.
In May 2022, India received a new hematology analyzer reagent plant from Nihon Kohden.
In October 2022, At the 2022 World Stroke Congress, Philips highlights the most recent developments in stroke treatment.
In October 2022, Philips improved MR radiation imaging and simulation for head and neck tumors.